TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22214287

Group type: EXPERIMENTAL
Intervention: Invasive strategy (stenting of the infarct-related coronary artery with abciximab as adjunct treatment)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 216

Group type: COMPARATOR
Intervention: Non-viable group
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Viable-conservative group
Number of subjects: 216
Study: 19753509

Group type: EXPERIMENTAL
Intervention: Outpatient client-centered psychotherapy (CCP)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Guided self help (GSH)
Number of subjects: 29
Study: 17331542

Group type: EXPERIMENTAL
Intervention: Glatiramer acetate (GA)
Number of subjects: 0
Study: 15776131

Group type: EXPERIMENTAL
Intervention: Montelukast sodium 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 12616819

Group type: EXPERIMENTAL
Intervention: Surgical resection distance of 2-3 cm proximally from the tumor
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Surgical resection distance of 4-6 cm proximally from the tumor
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Surgical resection distance of more than 6 cm proximally from the tumor
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Total gastrectomy for antral tumors
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Subtotal resection for antral tumors
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Subtotal or total gastrectomy based on preoperative histology for antral tumors
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Total gastrectomy for mid-third tumors
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Subtotal gastrectomy for mid-third tumors if resection distance is adequate
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Total gastrectomy for proximal third tumors
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Proximal resections
Number of subjects: 47
Study: 9797594

Group type: EXPERIMENTAL
Intervention: Health belief model reminder card
Number of subjects: 259

Group type: COMPARATOR
Intervention: Usual neutrally worded card
Number of subjects: 259
Study: 7662752

Group type: EXPERIMENTAL
Intervention: Relaxation technique (autogenic training and/or music)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Imagery training
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Biofeedback (BFB)
Number of subjects: 39
Study: 2766327

Group type: EXPERIMENTAL
Intervention: Xylitol (XYL) chewing gum
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Xylitol/Sorbitol (XYL/SOR) chewing gum
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Sorbitol (SOR) chewing gum
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (sucrose-containing gums)
Number of subjects: 28
Study: 84372

Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (normal subjects)
Number of subjects: 9
Study: 31982398

Group type: EXPERIMENTAL
Intervention: Exogenous progesterone administered intraperitoneally
Number of subjects: 0
Study: 31035017

Group type: EXPERIMENTAL
Intervention: ARD-3150 (inhaled liposomal ciprofloxacin)
Number of subjects: 582

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 582
Study: 27580820

Group type: EXPERIMENTAL
Intervention: Health promotion program
Number of subjects: 613

Group type: COMPARATOR
Intervention: Usual stroke management programs
Number of subjects: 613
Study: 25446547

Group type: EXPERIMENTAL
Intervention: MyoSure device for hysteroscopic removal of polyps and myomas
Number of subjects: 118
Study: 23033548

Group type: EXPERIMENTAL
Intervention: Spiritually based intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonspiritual comparison
Number of subjects: 0
Study: 22150146

Group type: EXPERIMENTAL
Intervention: External fixation (Hoffmann II compact non‐bridging)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Internal fixation (Micronail)
Number of subjects: 61
Study: 19684472

Group type: EXPERIMENTAL
Intervention: Cervarix
Number of subjects: 1106

Group type: COMPARATOR
Intervention: Gardasil
Number of subjects: 1106

Group type: EXPERIMENTAL
Intervention: Cervarix and Gardasil
Number of subjects: 1106
Study: 17884137

Group type: EXPERIMENTAL
Intervention: Vitamin complex supplementation
Number of subjects: 80
Study: 14681846

Group type: EXPERIMENTAL
Intervention: 100 g butter + 40 g alcohol + 50 g carbohydrate
Number of subjects: 11

Group type: COMPARATOR
Intervention: 100 g butter alone
Number of subjects: 11

Group type: COMPARATOR
Intervention: 100 g butter + 120 g carbohydrate
Number of subjects: 11
Study: 11226356

Group type: EXPERIMENTAL
Intervention: Information about smoking, sent under signature of the subject's general practitioner, certificates and posters intended to reinforce non-smoking behaviour.
Number of subjects: 2942

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 2942
Study: 9833177

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 8 mg o.i.d. (increased to 16 mg o.i.d. if necessary)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study: 7982389

Group type: EXPERIMENTAL
Intervention: Soil lead abatement
Number of subjects: 0
Study: 3154330

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 25 mg daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg twice daily
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combined treatment (Nifedipine + Chlorthalidone)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 16
Study: 31216575

Group type: EXPERIMENTAL
Intervention: PUFA diet enriched with oil-based margarine
Number of subjects: 83

Group type: COMPARATOR
Intervention: SFA diet enriched with butter
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: PUFA diet (normal-weight)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: PUFA diet (obese)
Number of subjects: 83

Group type: COMPARATOR
Intervention: SFA diet (normal-weight)
Number of subjects: 83

Group type: COMPARATOR
Intervention: SFA diet (obese)
Number of subjects: 83
Study: 28718697

Group type: EXPERIMENTAL
Intervention: Cervical disc replacement
Number of subjects: 151

Group type: COMPARATOR
Intervention: Cervical fusion
Number of subjects: 151
Study: 25259674

Group type: EXPERIMENTAL
Intervention: Levomilnacipran ER (40, 80, 120 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23466657

Group type: EXPERIMENTAL
Intervention: IPB perception with pitch change and preboundary lengthening but without the boundary pause.
Number of subjects: 0

Group type: COMPARATOR
Intervention: IPB perception with full prosodic marking (not explicitly tested in the study but implied as a comparison).
Number of subjects: 0
Study: 21220052

Group type: EXPERIMENTAL
Intervention: Computer algorithm for adjudication of cardiogenic shock events
Number of subjects: 5745

Group type: EXPERIMENTAL
Intervention: Computer algorithm for adjudication of congestive heart failure (CHF) events
Number of subjects: 5745

Group type: COMPARATOR
Intervention: Physician review for CHF events
Number of subjects: 5745

Group type: COMPARATOR
Intervention: Physician review for cardiogenic shock events
Number of subjects: 5745

Group type: EXPERIMENTAL
Intervention: Overall adjudication of suspected events
Number of subjects: 5745

Group type: EXPERIMENTAL
Intervention: Time to adjudication
Number of subjects: 5745

Group type: EXPERIMENTAL
Intervention: Source document collection
Number of subjects: 5745
Study: 19318651

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate‐impregnated sponge (CHGIS) dressings
Number of subjects: 1636

Group type: COMPARATOR
Intervention: 3-day dressing changes
Number of subjects: 1636

Group type: COMPARATOR
Intervention: 7-day dressing changes
Number of subjects: 1636
Study: 16505046

Group type: EXPERIMENTAL
Intervention: Diphenhydramine (1.0 mg/min over 50 minutes)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Histamine (0.32 microg/kg per minute over 30 minutes)
Number of subjects: 18
Study: 15599834

Group type: EXPERIMENTAL
Intervention: Metoprolol CR/XL
Number of subjects: 3540
Study: 11055324

Group type: EXPERIMENTAL
Intervention: Herbal tea
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo tea
Number of subjects: 40
Study: 9062618

Group type: EXPERIMENTAL
Intervention: Intravenous oxycodone hydrochloride 0.05 mg/kg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intranasal oxycodone hydrochloride 0.1 mg/kg
Number of subjects: 10
Study: 8330469

Group type: EXPERIMENTAL
Intervention: Low-dose enteric-coated aspirin (100 mg daily)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 3777411

Group type: EXPERIMENTAL
Intervention: 1% methohexital solution at 20 mg/kg body wt.
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: 1% methohexital solution at 25 mg/kg body wt.
Number of subjects: 223

Group type: COMPARATOR
Intervention: 5% methohexital solution
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: 1% methohexital solution
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: 1% methohexital solution at 15 mg/kg body wt.
Number of subjects: 223

Group type: COMPARATOR
Intervention: 5 mg/kg body wt. and 10 mg/kg body wt. dosages
Number of subjects: 223
Study: 29266290

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) treatment combined with fractional CO2 laser therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) administration after laser irradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no PRP treatment)
Number of subjects: 0
Study: 27130705

Group type: COMPARATOR
Intervention: Eplerenone (25 mg every other day, increased to 25 mg once daily on Day 30, and to 50 mg once daily on Day 60)
Number of subjects: 1066

Group type: EXPERIMENTAL
Intervention: Finerenone (2.5→5, 5→10, 7.5→15, 10→20, and 15→20 mg, uptitrated on Day 30)
Number of subjects: 1066

Group type: EXPERIMENTAL
Intervention: Finerenone (10→20 mg)
Number of subjects: 1066

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 1066
Study: 24012684

Group type: EXPERIMENTAL
Intervention: Standard wording
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intensified wording
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Repeated standard wording
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Repeated intensified wording
Number of subjects: 32
Study: 23406818

Group type: EXPERIMENTAL
Intervention: Acetate-free biofiltration (AFB)
Number of subjects: 371

Group type: COMPARATOR
Intervention: Bicarbonate hemodialysis (BD)
Number of subjects: 371
Study: 20062969

Group type: EXPERIMENTAL
Intervention: Matrix‐induced autologous chondrocyte implantation (MACI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Microfracture (MF)
Number of subjects: 60
Study: 18773341

Group type: EXPERIMENTAL
Intervention: Direct method using a 24 Fr bumper-button-type device
Number of subjects: 140

Group type: COMPARATOR
Intervention: Pull method
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Direct method
Number of subjects: 140
Study: 15734668

Group type: EXPERIMENTAL
Intervention: Zonisamide (ZNS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Arotinolol
Number of subjects: 0
Study: 12746087

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11775204

Group type: EXPERIMENTAL
Intervention: Intravenous mannitolum 250 ml
Number of subjects: 68

Group type: COMPARATOR
Intervention: Intravenous albumin 20 g
Number of subjects: 68
Study: 8858219

Group type: EXPERIMENTAL
Intervention: IGF‐I (8 micrograms.kg‐1.h‐1) for 5 days by continuous subcutaneous infusion
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline (NaCl 0.9%)
Number of subjects: 7
Study: 1324011

Group type: EXPERIMENTAL
Intervention: Mifepriston (RU 486)
Number of subjects: 1
Study: 6734705

Group type: EXPERIMENTAL
Intervention: Piretanide (12, 24, 48, 96 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Piretanide (48 mg and 96 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Furosemide (given in a ratio of 3.33:1 to piretanide)
Number of subjects: 10
Study: 30957673

Group type: EXPERIMENTAL
Intervention: Cold water immersion (CWI)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study: 29471100

Group type: EXPERIMENTAL
Intervention: Dynamic brain networks from functional magnetic resonance imaging (fMRI) data
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Machine learning and functional brain networks
Number of subjects: 1
Study: 26869012

Group type: EXPERIMENTAL
Intervention: Quetiapine 150 mg XL for seven nights
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Quetiapine 150 mg XL
Number of subjects: 20
Study: 25081182

Group type: EXPERIMENTAL
Intervention: Updated microsimulation model of HPV infection and cervical cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm of the Costa Rica Vaccine Trial (2004-2010)
Number of subjects: 0
Study: 22891782

Group type: EXPERIMENTAL
Intervention: Intravascular laser irradiation of blood (ILIB) therapy for 1 hour daily for 15 days over 3 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intravascular laser irradiation of blood (ILIB) therapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham group (ILIB with no laser power)
Number of subjects: 24
Study: 20618978

Group type: EXPERIMENTAL
Intervention: Conventional longitudinal change
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Patient perceived change
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Discrepancy between conventional longitudinal change and patient perceived change
Number of subjects: 103
Study: 19104122

Group type: EXPERIMENTAL
Intervention: Topical negative pressure (TNP) wound closure using a locally constructed device
Number of subjects: 48

Group type: COMPARATOR
Intervention: Wet-to-dry gauze dressings (control)
Number of subjects: 48
Study: 16154478

Group type: EXPERIMENTAL
Intervention: Aspirin 500 mg
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Aspirin 1000 mg
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Acetaminophen 500 mg
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg
Number of subjects: 392

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: All active treatments (Aspirin and Acetaminophen)
Number of subjects: 392
Study: 12573299

Group type: EXPERIMENTAL
Intervention: Methyltestosterone (MT) 40 mg/day for 3 days, then 240 mg/day for 3 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Methyltestosterone (MT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10505677

Group type: EXPERIMENTAL
Intervention: Reverse transcription-polymerase chain reaction (RT-PCR) with fluorogenic probes for detecting the T215Y mutation.
Number of subjects: 0
Study: 7546004

Group type: EXPERIMENTAL
Intervention: EEG-sleep measures
Number of subjects: 56
Study: 1683189

Group type: EXPERIMENTAL
Intervention: Levocabastine nasal spray (0.5 mg/mL)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sodium cromoglycate nasal spray (20 mg/mL)
Number of subjects: 56
Study: 6793058

Group type: EXPERIMENTAL
Intervention: Vitamin D supplements (1000 iu daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (unsupplemented)
Number of subjects: 0
Study: 30929856

Group type: EXPERIMENTAL
Intervention: Arts-integrated science units
Number of subjects: 16

Group type: COMPARATOR
Intervention: Traditional science instruction (control)
Number of subjects: 16
Study: 28421633

Group type: EXPERIMENTAL
Intervention: Tulathromycin IM q 7 days (n = 80)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Azithromycin-rifampin, orally q24h (n = 80)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Untreated controls (n = 80)
Number of subjects: 240
Study: 25803626

Group type: EXPERIMENTAL
Intervention: Synbiotics (Lactobacillus acidophilus 10, 1 × 10(9)CFU; Lactobacillus rhamnosus HS 111, 1 × 10(9) CFU; Lactobacillus casei 10, 1 × 10(9) CFU; Bifidobacterium bifidum, 1 × 10(9)CFU; fructooligosaccharides (FOS) 100 mg), administered twice daily for 14 days
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (Control group C)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Synbiotics
Number of subjects: 46
Study: 23256143

Group type: EXPERIMENTAL
Intervention: D2 (ergocalciferol)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: D3 (cholecalciferol)
Number of subjects: 52
Study: 21076316

Group type: EXPERIMENTAL
Intervention: CVD risk reduction intervention (16 weeks) including 150 minutes of regular exercise per week, 200-300 kcal reduced daily diet, one-on-one psychobehavioral counseling, and telephone coaching
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group received a booklet with basic diabetic education
Number of subjects: 43
Study: 19784816

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day for 6 months
Number of subjects: 72
Study: 17258855

Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg OD
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg OD
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Combination of alfuzosin and sildenafil
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 62
Study: 15197377

Group type: EXPERIMENTAL
Intervention: Consultation and training provided by nurse educators on best practice protocols for prevention of decline in activities of daily living, pain, and depression.
Number of subjects: 2
Study: 14700217

Group type: EXPERIMENTAL
Intervention: Adapalene cream 0.1%
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Adapalene gel 0.1%
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Tretinoin formulations (Avita cream 0.025%, Retin‐A cream 0.025%, Retin‐A cream 0.05%, Retin‐A Micro gel 0.1%, and generic cream 0.025%)
Number of subjects: 31

Group type: COMPARATOR
Intervention: White petrolatum (negative control)
Number of subjects: 31
Study: 10216903

Group type: EXPERIMENTAL
Intervention: Nurse-led service for blood product support
Number of subjects: 45
Study: 7605761

Group type: EXPERIMENTAL
Intervention: Low-dose epinephrine (EPI) intravenous infusion
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Phenylephrine (PHE) intravenous infusion
Number of subjects: 49
Study: 2194537

Group type: EXPERIMENTAL
Intervention: Increased dose of radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Addition of endocrine treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Addition of cytostatic treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Systemic treatment
Number of subjects: 0
Study: 85872

Group type: EXPERIMENTAL
Intervention: Pectin added to glucose solution
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Propantheline (pharmacological inhibition of gastric emptying)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Guar gum and pectin added to paracetamol
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (without pectin or guar gum)
Number of subjects: 21
Study: 31648210

Group type: EXPERIMENTAL
Intervention: Method employing geometric and dosimetric information for DVH prediction
Number of subjects: 106

Group type: COMPARATOR
Intervention: Method utilizing only geometric information for DVH prediction
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Overall DVH prediction model using geometric and dosimetric information
Number of subjects: 106
Study: 27817116

Group type: EXPERIMENTAL
Intervention: Modified tarsal strip technique
Number of subjects: 184

Group type: COMPARATOR
Intervention: Conventional tarsal strip
Number of subjects: 184
Study: 26543007

Group type: EXPERIMENTAL
Intervention: General Cognitive Training (CT)
Number of subjects: 2912

Group type: EXPERIMENTAL
Intervention: Reasoning Cognitive Training (CT)
Number of subjects: 2912
Study: 23566948

Group type: EXPERIMENTAL
Intervention: 60° needle angle
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 90° needle angle
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: BMI ≤ 25
Number of subjects: 19

Group type: COMPARATOR
Intervention: Reactogenicity
Number of subjects: 19
Study: 21447136

Group type: EXPERIMENTAL
Intervention: Integrated care (group I)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Usual care (group U)
Number of subjects: 102
Study: 19622755

Group type: EXPERIMENTAL
Intervention: Peer counseling intervention
Number of subjects: 27
Study: 17593884

Group type: EXPERIMENTAL
Intervention: Family expressed emotion (EE) components: rejection, warmth, protectiveness, and fusion in established disorder samples.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Family expressed emotion (EE) components in mothers.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Family expressed emotion (EE) components in fathers.
Number of subjects: 0
Study: 15198784

Group type: EXPERIMENTAL
Intervention: Gestational hypertension
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pre-eclampsia
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pre-eclampsia with HELLP syndrome
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (normotensive women)
Number of subjects: 80
Study: 11465516

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate, 200 mg, weekly intramuscular injections
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (sesame seed oil)
Number of subjects: 32
Study: 9709876

Group type: EXPERIMENTAL
Intervention: RRV‐TV
Number of subjects: 2398

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2398
Study: 31228026

Group type: EXPERIMENTAL
Intervention: Enhanced PMTCT Intervention (EI) - three group and three individual intervention sessions
Number of subjects: 683

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Enhanced PMTCT Intervention (EI)
Number of subjects: 683
Study: 28393669

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A + serial casting
Number of subjects: 80

Group type: COMPARATOR
Intervention: Botulinum toxin type A only
Number of subjects: 80
Study: 25528430

Group type: EXPERIMENTAL
Intervention: niacin + laropiprant (ERN/LPR)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: fenofibrate (FFB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: nondiabetic patients with normal HDL
Number of subjects: 30